ABOUT VHIO
VHIO is a leading comprehensive cancer center of excellence where its scientists and physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer:
PROGRAMS & GROUPS
Scientific activity at VHIO is structured across for major programs: Preclinical, Translational, Clinical Research, and Core Technologies. Each incorporates research teams of excellence dedicated to harnessing and rapidly translating discoveries into tangible benefits for patients.
NEWS
Follow us:
DIRECTION &
PRINCIPAL INVESTIGATORS
Research at VHIO is led by our Director, Josep Tabernero, and supported by a consultative body, VHIO’s Scientific Committee. A total of 26 renowned Principal Investigators manage and run VHIO’s major research themes and programs.
SCIENTIFIC
REPORT
2021
REPORT
2021
CLINICAL TRIALS
Driving drug development & targeted therapies against cancer, VHIO has become a leading reference in drug discovery from concept to clinic:
PROJECTS & INSTITUTIONAL PROGRAMS
Research at VHIO is made possible through the support received from private institutions, funding entities, companies and individuals, as well as International and National Competitive Grants. Find out more about our supporters, current projects and VHIO´s Scientific Coordination Area:
EVENTS
VHIO organizes symposia of excellence and ad-hoc courses & workshops through which it shares its expertise and promotes debate and exchange of the highest degree:
